Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:

Expert Q&As

The company's mission is to care for the world—one person at a time. Just ask Chief Medical Officer Joanne Waldstreicher, M.D., who's been leading the charge to improve the process by which very sick patients may apply for access to investigational medications.
A Q&A with Gary Eichenbaum, Ph.D., Vice President, Translational Science and Safety, Office of the Chief Medical Officer, Johnson & Johnson
We asked Aran Maree, M.D., Chief Medical Officer for Janssen Pharmaceuticals, to give us the scoop on what to do with out-of-date drugs.
A Q&A with Jesse Berlin, Sc.D., Vice President and Global Head of Epidemiology, Johnson & Johnson, about why open access in scientific publishing is important and how Johnson & Johnson is helping pave the way forward.
Johnson & Johnson's Chief Medical Officer for Global Public Health had a front row seat at the World Economic Forum this year as part of a new coalition aimed at helping to advance vaccine development for pathogens.
Health care companies develop innovative new medicines and products to meet patient needs and improve lives. Once devices and medicines are in use, our group evaluates how they perform in a real-world setting, looking at patient outcomes as well as the impact on cost of care.
The OCMO takes an evidence- and science-based, ethics- and values-driven approach to medical safety—with an emphasis on transparency. This has led to the development of policies and initiatives that keep the needs of patients and consumers at the center of our efforts.
Medicine safety tips from Dr. Ed Kuffner, Chief Medical Officer, Johnson & Johnson Consumer.
Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.